Ritchard Rosen, DPM
Podiatrist · Englewood, NJNPI 1972546430
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $35,078 of the $43,622 with a category attached, or 80.4%. 39 manufacturers reported payments, led by Osteomed LLC at 49.3% of the total. Among podiatrist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 299 payments — averaging $145.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osteomed LLC$22K
- Acumed LLC$14K
- Stryker$3K
- Smith+Nephew$2K
- Integra Lifesciences Corporation$972
- Kerecis Limited$565
- plus $2K from 33 others
Across 1 payment — averaging $675.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Reddress LTD$675
What the payments were for
- Royalty or licence$35,07880%
- Food & beverage$8,10719%
- Other$4371%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osteomed LLC | 10 | $21,504 |
| Acumed LLC | 13 | $13,574 |
| Stryker | 41 | $3,370 |
| Smith+Nephew | 130 | $1,633 |
| Integra Lifesciences Corporation | 16 | $972 |
| Kerecis Limited | 6 | $565 |
| Organogenesis Inc. | 11 | $386 |
| Treace Medical Concepts, Inc. | 7 | $374 |
| AbbVie(2 entities) | 14 | $199 |
| Zimmer Biomet | 5 | $133 |
| Seapearl East, Inc | 3 | $80 |
| Johnson & Johnson | 3 | $66 |
| DJO, LLC | 2 | $66 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $59 |
| Royal Biologics, Inc. | 1 | $52 |
| Medshape, Inc. | 2 | $51 |
| Convatec Inc. | 2 | $42 |
| Axogen | 1 | $37 |
| Trilliant Surgical LLC. | 1 | $37 |
| KCI USA, Inc. | 3 | $37 |
| Paragon 28, Inc. | 2 | $34 |
| Orthofix Medical, Inc. | 1 | $29 |
| Next Science LLC | 1 | $29 |
| Amgen | 2 | $28 |
| Zimvie Inc. | 1 | $27 |
| Medtronic | 1 | $26 |
| Merck | 2 | $25 |
| Sandoz | 2 | $24 |
| Biocomposites Inc | 1 | $22 |
| Heron Therapeutics, Inc. | 2 | $21 |
| Urgo Medical North America, LLC | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $16 |
| Cashflow Solutions, LLC | 1 | $16 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| IBSA Pharma Inc. | 1 | $13 |
| GRT US Holding, Inc. | 1 | $11 |
| Aroa Biosurgery Incorporated | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-Encompass$21,504
- OsteoMed$13,574
- Kerecis SurgiClose$1,321
- INTEGRA$800
- CITREFIX$742
- Kerecis Omega3 Marigen$532
- INFINITY$474
- INFINITY ADAPTIS$395
- Kerecis GraftGuide$330
- ALLOWRAP$308
- CYTAL$291
- INTEGRA DERMAL REGENERATION TEMPLATE$267
- PRIMATRIX$267
- AUGMENT INJECTABLE$258
- VARIAX$169
- PICO$147
- RENASYS TOUCH$147
- MICROMATRIX$147
- CHARLOTTE$140
- ORTHOLOC 2 LAPIFUSE$140
How this compares
$43,622 in reported general payments places this provider in the 95th percentile of 382 podiatrist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 29 | $59,162 |
| Pregabalin | 109 | $4,259 |
| Ciclopirox | 14 | $628 |
| Ammonium Lactate | 18 | $319 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $300 |
| Gabapentin | 20 | $214 |
| Doxycycline Hyclate | 25 | $209 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $133 |
| Meloxicam | 55 | $117 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $81 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,633 | $59,16229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 382 podiatrist providers in New Jersey.
Other podiatrist in Englewood
- Jonathan RichardsEnglewood$79K
- Jeffrey CohenEnglewood$10K
- Katherine ChenEnglewood$7K
- Gregory KaufmanEnglewood$6K
- Justin FlemingSomerset$1.2M
- Eric BaskinManahawkin$298K
- Jack BondiSewell$53K
- Matthew WohlgemuthHammonton$49K
- Michael HuchitalLyndhurst$41K
- Jeffrey GewirtzPark Ridge$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.